DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Yes. NovoCare direct cash-pay is $499/month for uninsured patients — same FDA-approved Wegovy as retail pharmacy, no insurance required.
Wegovy is available without insurance through three pathways: (1) NovoCare direct cash-pay — $499/month for uninsured or non-Wegovy-covered patients, ordered through novocare.com, ships from Novo Nordisk pharmacy; (2) Retail pharmacy cash-pay — $1,349/month at most pharmacies (most expensive path); (3) Compounded semaglutide via telehealth platforms (Hims, Ro, Sequence) — $199-299/month, not FDA-approved as Wegovy, regulatory wind-down ongoing post-shortage end. NovoCare direct is the most reliable cash-pay route — same drug as insurance-covered Wegovy, manufacturer-direct. Compounded is cheapest but carries regulatory uncertainty and quality variance.
Editorial answer reviewed by a board-certified clinician. Not medical advice. Coordinate treatment decisions with your prescriber.